US Broker Ratings

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 23.47% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX), a prominent name in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and generic pharmaceuticals, offers intriguing opportunities for investors. Headquartered..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 4.74% Upside Potential in the Medical Instruments Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable entity in the healthcare sector, particularly in the medical instruments and supplies industry. With a staggering market capitalization of $205.22 billion,..

DaVita Inc. (DVA) Stock Analysis: Unveiling a Potential 25% Upside for Savvy Investors

DaVita Inc. (DVA), a leading provider in the healthcare sector, focuses on kidney dialysis services, catering primarily to patients with chronic kidney failure. With a market cap of $8.24 billion,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 6.51% Upside and Robust Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) stands out as a formidable player in the healthcare sector, with a focus on addressing unmet medical needs through its innovative drug portfolio. As a..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating Growth Potential Amidst a Challenging Market

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a complex investment landscape for individual investors. With a market..

Insulet Corporation (PODD) Stock Analysis: A 30% Upside Potential with Strong Buy Ratings

Insulet Corporation (PODD), a key player in the healthcare sector specializing in innovative medical devices, presents a compelling investment opportunity for those interested in the fast-evolving field of diabetes management...

Investor Outlook: Encompass Health Corporation (EHC) Offers Compelling 31.90% Upside Potential

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its robust growth metrics and significant..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Opportunities with a 3.57% Upside Potential

Centene Corporation (NYSE: CNC), a prominent player within the healthcare sector, is uniquely positioned in the U.S. healthcare plans industry. With a market capitalization of $19.18 billion, Centene serves a..

Solventum Corporation (SOLV)

⚠️ No article content returned.

..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 24.82% Potential Upside in the Healthcare Sector

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is capturing investor attention due to its compelling market position and potential upside. With a market capitalization of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with 15% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $37.58 billion, this North Carolina-based company..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 13.63% Potential Upside in a Challenging Market

Pfizer, Inc. (NYSE: PFE) remains a cornerstone of the healthcare sector, renowned for its extensive portfolio of biopharmaceutical products and a legacy dating back to 1849. With a market capitalization..

Insmed Incorporated (INSM) Investor Outlook: Strong Revenue Growth Amidst High Potential Upside

Investors looking to capitalize on the biotechnology sector’s promising landscape should turn their attention to Insmed Incorporated (NASDAQ: INSM). With a significant market cap of $37.29 billion, Insmed continues to..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 22.33% Potential Upside for Investors

Fresenius Medical Care AG (NYSE: FMS), headquartered in Bad Homburg, Germany, is a key player in the healthcare sector, specifically within the medical care facilities industry. Known for its global..

Illumina, Inc. (ILMN) Stock Analysis: A Look at Growth Potential Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN) stands at the intersection of healthcare innovation and genetic research, offering advanced sequencing and array-based solutions to a global market. As a leader in the diagnostics..

Biogen Inc. (BIIB)

⚠️ No article content returned.

..

Labcorp Holdings Inc. (LH) Stock Analysis: Unpacking a 19% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands at a fascinating juncture, offering a wealth of opportunities for investors seeking exposure in the healthcare sector, particularly within diagnostics and research. With a..

Incyte Corporation (INCY): Valuation Insights and Investor Outlook Amid Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY), a biopharmaceutical powerhouse, continues to capture investor attention with its strategic focus on innovative therapies across a range of complex medical conditions. With a market cap..

Hologic, Inc. (HOLX) Investor Outlook: Analyzing Growth Potential in Medical Instruments & Supplies

Hologic, Inc. (NASDAQ: HOLX), a leading player in the healthcare sector, is strategically positioned within the medical instruments and supplies industry. With a market capitalization of $16.71 billion, Hologic stands..

ResMed Inc. (RMD) Stock Analysis: Unlocking a 19% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector, has consistently captured investor attention with its innovative solutions in the medical instruments and supplies industry. Headquartered in San Diego,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds